ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	63,405	50,097	50,201	39,203	38,625
Short-Term Investments	9,518	40,000	-	44,000	84,001
Trading Asset Securities	48,001	-	-	10,013	18,011
Cash & Short-Term Investments	120,924	90,097	50,201	93,216	140,636
Cash Growth	34.22%	79.47%	-46.15%	-33.72%	116.23%
Accounts Receivable	67,846	120,566	94,210	62,949	45,435
Other Receivables	1,972	1,500	3,131	1,499	1,236
Receivables	69,817	122,066	97,341	64,448	46,671
Inventory	126,963	120,736	107,623	80,809	45,401
Prepaid Expenses	9,120	11,901	5,818	5,039	1,798
Other Current Assets	3,254	3,577	2,251	628.76	1,107
Total Current Assets	330,078	348,378	263,234	244,142	235,613
Property, Plant & Equipment	338,695	280,105	257,885	210,190	175,634
Long-Term Investments	8,913	10,728	11,492	13,264	7,756
Goodwill	10,599	9,950	8,947	8,455	8,044
Other Intangible Assets	5,933	3,513	3,532	4,164	1,952
Long-Term Deferred Tax Assets	7,352	7,498	17,127	15,732	14,699
Other Long-Term Assets	20,305	15,264	8,436	2,619	1,872
Total Assets	721,876	675,436	570,652	498,565	445,570
Accounts Payable	10,646	17,661	18,095	12,865	4,694
Accrued Expenses	4,566	8,264	9,365	6,558	3,097
Short-Term Debt	30,000	20,878	105,854	-	-
Current Portion of Long-Term Debt	42,217	8,333	8,293	15,000	-
Current Portion of Leases	1,158	1,039	1,185	587.24	894.1
Current Income Taxes Payable	7,115	4,430	2,377	1,322	-
Current Unearned Revenue	6,818	2,391	-	-	-
Other Current Liabilities	30,761	20,748	34,054	16,243	9,925
Total Current Liabilities	133,281	83,745	179,224	52,575	18,610
Long-Term Debt	43,255	159,689	16,707	91,451	125,646
Long-Term Leases	1,512	2,143	2,481	479.1	386.54
Long-Term Unearned Revenue	2,738	2,791	-	956.3	1,698
Other Long-Term Liabilities	37,333	39,578	31,138	27,071	2,451
Total Liabilities	218,885	288,530	229,549	172,533	148,817
Common Stock	10,076	9,404	9,404	9,404	9,328
Additional Paid-In Capital	315,593	225,940	195,747	195,714	174,919
Retained Earnings	159,437	135,729	126,893	115,590	111,634
Comprehensive Income & Other	18,025	13,476	5,587	2,266	-552.72
Total Common Equity	503,132	384,550	337,632	322,974	295,328
Minority Interest	-141.19	2,356	3,471	3,058	1,425
Shareholders' Equity	502,991	386,906	341,103	326,033	296,753
Total Liabilities & Equity	721,876	675,436	570,652	498,565	445,570
Total Debt	118,142	192,082	134,521	107,517	126,927
Net Cash (Debt)	2,782	-101,984	-84,320	-14,301	13,709
Net Cash Growth	-	-	-	-	-72.05%
Net Cash Per Share	142.64	-5422.17	-4483.00	-766.21	734.85
Filing Date Shares Outstanding	20.15	18.81	18.81	18.81	18.66
Total Common Shares Outstanding	20.15	18.81	18.81	18.81	18.66
Working Capital	196,797	264,634	84,010	191,567	217,003
Book Value Per Share	24965.77	20445.26	17950.76	17171.46	15830.19
Tangible Book Value	486,600	371,088	325,153	310,355	285,333
Tangible Book Value Per Share	24145.44	19729.50	17287.30	16500.56	15294.42
Land	60,200	60,024	59,999	52,910	52,908
Buildings	149,266	146,984	118,168	102,362	103,273
Machinery	203,768	195,642	157,855	120,141	115,304
Construction In Progress	93,149	20,794	44,421	50,144	12,071

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.